Q BIOMED INC.: 10-Q filed 2020-10-14
What Q BIOMED INC. reported in its quarterly report filed 2020-10-14 (fiscal Q3 2020): 31 published measures, 86 facts as tagged in accession 0001104659-20-114948.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-10-14
- Fiscal period
- fiscal Q3 2020
- Accession
- 0001104659-20-114948 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Q BIOMED INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 1,885,123 | USD | |
| At 2019-11-30 | 640,298 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 1,758,516 | USD | |
| At 2019-11-30 | 5,685,639 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 126,607 | USD | |
| At 2020-05-31 | 2,113,038 | USD | |
| At 2019-11-30 | -5,045,341 | USD | |
| At 2019-08-31 | -6,042,795 | USD | |
| At 2019-05-31 | -4,360,476 | USD | |
| At 2018-11-30 | -105,728 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 1,326,359 | USD | |
| At 2019-11-30 | 172,636 | USD | |
| At 2019-08-31 | 301,673 | USD | |
| At 2018-11-30 | 2,684,413 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-06-01 to 2020-08-31 | -2,257,861 | USD | 92 |
| 2019-12-01 to 2020-08-31 | -10,062,126 | USD | 275 |
| 2019-06-01 to 2019-08-31 | -2,546,688 | USD | 92 |
| 2018-12-01 to 2019-08-31 | -7,809,917 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-12-01 to 2020-08-31 | -4,761,277 | USD | 275 |
| 2018-12-01 to 2019-08-31 | -3,075,990 | USD | 274 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-06-01 to 2020-08-31 | 15,000 | USD | 92 |
| 2019-12-01 to 2020-08-31 | 30,000 | USD | 275 |
| 2019-06-01 to 2019-08-31 | 0 | USD | 92 |
| 2018-12-01 to 2019-08-31 | 0 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-12-01 to 2020-08-31 | 5,915,000 | USD | 275 |
| 2018-12-01 to 2019-08-31 | 693,250 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | -52,456,003 | USD | |
| At 2019-11-30 | -42,393,877 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-12-01 to 2020-08-31 | 4,982,446 | USD | 275 |
| 2018-12-01 to 2019-08-31 | 1,349,608 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 1,472,623 | USD | |
| At 2019-11-30 | 190,298 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-06-01 to 2020-08-31 | 9,025 | USD | 92 |
| 2019-12-01 to 2020-08-31 | 291,626 | USD | 275 |
| 2019-06-01 to 2019-08-31 | 476,627 | USD | 92 |
| 2018-12-01 to 2019-08-31 | 1,137,271 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 1,668,420 | USD | |
| At 2019-11-30 | 5,238,304 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 357,973 | USD | |
| At 2019-11-30 | 652,051 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 412,500 | USD | |
| At 2019-11-30 | 450,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 12,300 | USD | |
| At 2019-11-30 | 0 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-06-01 to 2020-08-31 | 2,105,320 | USD | 92 |
| 2019-12-01 to 2020-08-31 | 9,556,727 | USD | 275 |
| 2019-06-01 to 2019-08-31 | 1,754,983 | USD | 92 |
| 2018-12-01 to 2019-08-31 | 6,079,568 | USD | 274 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-06-01 to 2020-08-31 | -143,516 | USD | 92 |
| 2019-12-01 to 2020-08-31 | -163,211 | USD | 275 |
| 2019-06-01 to 2019-08-31 | 0 | USD | 92 |
| 2018-12-01 to 2019-08-31 | 0 | USD | 274 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-06-01 to 2020-08-31 | 158,516 | USD | 92 |
| 2019-12-01 to 2020-08-31 | 193,211 | USD | 275 |
| 2019-06-01 to 2019-08-31 | 0 | USD | 92 |
| 2018-12-01 to 2019-08-31 | 0 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-06-01 to 2020-08-31 | 613,707 | USD | 92 |
| 2019-12-01 to 2020-08-31 | 896,908 | USD | 275 |
| 2019-06-01 to 2019-08-31 | 786,600 | USD | 92 |
| 2018-12-01 to 2019-08-31 | 2,672,715 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 22,650,685 | shares | |
| At 2019-11-30 | 19,709,068 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 45,345,017 | USD | |
| At 2019-11-30 | 37,328,827 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 90,096 | USD | |
| At 2019-11-30 | 447,335 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 1,265,571 | USD | |
| At 2019-11-30 | 1,145,660 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-08-31 | 133,964 | USD | |
| At 2019-11-30 | 17,662 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-06-01 to 2020-08-31 | -2,404,088 | USD | 92 |
| 2019-12-01 to 2020-08-31 | -10,775,770 | USD | 275 |
| 2019-06-01 to 2019-08-31 | -2,546,688 | USD | 92 |
| 2018-12-01 to 2019-08-31 | -7,809,917 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-06-01 to 2020-08-31 | 1,491,613 | USD | 92 |
| 2019-12-01 to 2020-08-31 | 8,659,819 | USD | 275 |
| 2019-06-01 to 2019-08-31 | 968,383 | USD | 92 |
| 2018-12-01 to 2019-08-31 | 3,406,853 | USD | 274 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-12-01 to 2020-08-31 | 0 | USD | 275 |
| 2018-12-01 to 2019-08-31 | 31,524 | USD | 274 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-12-01 to 2020-08-31 | 0 | USD | 275 |
| 2018-12-01 to 2019-08-31 | 0 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-12-01 to 2020-08-31 | 12,300 | USD | 275 |
| 2018-12-01 to 2019-08-31 | 0 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-12-01 to 2020-08-31 | -187,667 | USD | 275 |
| 2018-12-01 to 2019-08-31 | 1,646,699 | USD | 274 |
Inspect the source
- Entity
- Q BIOMED INC. / CIK 0001596062
- Captured
- SEC response SHA-256
f89c4e51720d8de34ddffc303f833ea01697bd4742662935a9f3cf09e3e7efbc
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001596062.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))